New Analysis: Biological Risks Must Be Among Top Security Priorities
In a new
article published in Health Security,
NTI senior director for global biological policy and programs Beth
Cameron underscores the importance of preparing for catastrophic biological
threats.
“While the world continues to receive wake-up calls –
including recent outbreaks of pandemic influenza, MERS, Ebola, and Zika – two things
are increasingly apparent,” Cameron said. “First, society is changing in ways
that are likely to make a rapidly spreading biological agent even more deadly
and destabilizing. Second, the world is
largely unprepared for a fast-spreading, highly lethal, politically
destabilizing biological event.”
The article is in response to a new framework
published by the Johns Hopkins Center for Health Security that aims to advance scientific
dialogue about potential global catastrophic biological risks (GCBRs).
Read the full article and find other responses
to the framework here.
Stay Informed
Sign up for our newsletter to get the latest on nuclear and biological threats.
NTI and Munich Security Conference Convene Global Leaders for Fourth Annual Tabletop Exercise on Reducing High-Consequence Biological Threats
NTI Co-Chairman and CEO Ernest J. Moniz and Munich Security Conference (MSC) Chairman Ambassador Wolfgang Ischinger virtually convened 19 global leaders and experts on February 17, 2022 for a high-level tabletop exercise focused on reducing high-consequence biological threats.
NTI | bio Workshop Advances Efforts to Strengthen International Capabilities to Investigate High-Consequence Biological Events of Unknown Origin
NTI | bio hosted a workshop to explore the prospect of a new, internationally credible “Joint Assessment Mechanism” to rapidly investigate high-consequence biological events of unknown origin.
New Report Offers Actions to Prevent Catastrophic Biological Risk
National and global leaders have a responsibility to take action now to prevent future biological events that could match or surpass the impact of COVID-19.
